Collegium Pharmaceutical COLL
NASDAQ COLL
$22.91 -0.32 (-1.38%)
As of: Oct 21, 2026 · 3:59 PM EDT

Collegium Pharmaceutical (COLL) Preferred Stock Liabilities (2014 - 2015)

Updated

Collegium Pharmaceutical's Preferred Stock Liabilities was $119.66 million in Q1 2015, up 55.2% from the prior quarter.

Analysis

Collegium Pharmaceutical (COLL) Preferred Stock Liabilities (2014 - 2015) Analysis & Trends

At the end of FY2014, Preferred Stock Liabilities at Collegium Pharmaceutical came in at $77.11 million, up 25.1% from FY2013.

  • In earlier years, Preferred Stock Liabilities was $61.65 million in FY2013.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Preferred Stock Liabilities (Qtr)
1 Eli Lilly 1,136.97 Bn 1,105.55 Bn 19.71 Bn -
2 Johnson & Johnson 619.72 Bn 538.25 Bn 17.26 Bn -
3 AbbVie 503.40 Bn 476.52 Bn 12.70 Bn -
4 Merck 370.15 Bn 324.53 Bn 12.21 Bn -
5 Novartis Ag 298.64 Bn 262.63 Bn 11.24 Bn -
6 Astrazeneca 261.07 Bn 234.76 Bn 12.86 Bn -
7 Amgen 237.00 Bn 192.40 Bn 7.24 Bn -
8 Gilead Sciences 191.24 Bn 165.43 Bn 6.22 Bn -
9 Pfizer 170.31 Bn 116.96 Bn 10.94 Bn -
10 Collegium Pharmaceutical 744.00 Mn -479.76 Mn 110.29 Mn -
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2015 119.66 Mn
Dec 31, 2014 77.11 Mn
API Access

Collegium Pharmaceutical Preferred Stock Liabilities API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=preferred-stock-liabilities&ticker=COLL&period=max&api_key=YOUR_API_KEY